February 22, 2021
The Patent Trial and Appeal Board said it won't review six Allergan patents covering the company's injectable skin filler Juvederm, despite expressing skepticism toward them, after Allergan announced it has inked a licensing agreement with the low-cost rival challenging the patents.
January 24, 2020
Allergan can escape allegations that it improperly obtained its patents in a lawsuit against a competitor over its injectable dermal filler Juvederm, a Delaware federal court ruled Friday.